Big Pharma Split Corp Class A - Equity (PRM)

CUSIP: L7579L106

Q1 2024 13F Holders as of 31 Mar 2024

Share change
-2,281,277
Put/Call ratio
0.37%
SEC-reported price per share
$7.42
Number of holders
159
Value change
-$6,096,867
Number of buys
85
Open additional details 1 more signal available
Number of sells
66

Security key

L7579L106

Report period

Q1 2024

Institutions

159

Top holders

10

Ownership snapshot

Top reported holders of PRM - Big Pharma Split Corp Class A - Equity (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
WINDACRE PARTNERSHIP LLC
Disclosed value leader
WINDACRE PARTNERSHIP LLC
Comparable rows
0/15
Latest evidence
31 Dec 2023
13F Highest disclosed value: $99,360,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

WINDACRE PARTNERSHIP LLC has the largest disclosed position value at $99.36M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens WINDACRE PARTNERSHIP LLC's linked filing trail.
Disclosed position value Top 5
WINDACRE PARTNERSHIP LLC $99.36M
BlackRock Finance, Inc. $53.39M
PRINCIPAL FINANCIAL GROUP INC $48.39M
JPMORGAN CHASE & CO $39.61M
Meritage Group LP $36.8M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
WINDACRE PARTNERSHIP LLC
13F
Company
13F
—
denominator unverified
$99,360,000
21,600,000 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$53,390,194
11,606,564 shares
— 31 Dec 2023
PRINCIPAL FINANCIAL GROUP INC
13F
Company
13F
—
denominator unverified
$48,387,247
10,518,966 shares
— 31 Dec 2023
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$39,606,962
8,610,209 shares
— 31 Dec 2023
Meritage Group LP
13F
Company
13F
—
denominator unverified
$36,800,000
8,000,000 shares
— 31 Dec 2023
Matrix Capital Management Company, LP
13F
Company
13F
—
denominator unverified
$34,327,500
7,462,500 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
159
Shares
128,060,788
Rows available
159
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q2 2026 Across Filers

Q2 2026 holders
3
Q1 2024 holders
159
Holder diff
156
Investor Q2 2026 Shares Q1 2024 Shares Share Diff Share Chg % Q2 2026 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .